Innovative ideas & creative contributions

At BBM there’s always room for new talented people!

We invite everybody to submit an abstract, specially the new generations. At the BBM there’s always room for new talented people.

Presenters will be given 4 minutes to present their case and 2 minutes for discussion and the best presentation will be voted for by the audience.

Please, read carefully the abstract’s format requirements beside. All the documents that are not following these requirements will be automatically rejected from the selection process.

Key Dates:
  • Abstract submission deadline: 14th February 2020
  • Notification of acceptance: 24th February 2020
  • Presentation delivery: When you reach the meeting
  • Free paper session: 11th March 2020 - 15.30h.
Abstract's format requirements:

All abstracts should be written in English (300 words) and sent in Word format with the title of the abstract as the file name, using the template enclosed.

All margins should be set at 2,5 cm. Please avoid using headers and footnotes, references should be given at the end of the paper.

The citation number of bibliographical references in text must be enclosed in square brackets [1]. Maximum 5 citations should be enclosed.

No pictures can be included within the abstract text.

  • Abstract title: Arial, 14-point, bold, centered
  • Authors name(s): Arial, 12-point, bold, centered
  • Name of the Institution: Arial, 10-point, normal, centered
  • Topic: Arial, 10-point, bold, fully justified.
  • Abstract content (maximum of 300 words): Arial, 10-point, normal, fully justified. Please, do not place any additional blank lines between paragraphs.


7th October 2020 - 15.30 - 17.00h

15.30 – 15.38h:

The role of extracellular matrix in endothelial cell organization and functions – Michael V. Paukshto

15.39 – 15.47h:

The triple surgical treatment method for chronic lymphedema using aligned nanofibrillar collagen scaffolds – Youna Choi

15.48 – 15.56h:

Prophylactic lymphaticovenous anastomoses for resection of soft tissue tumors of the thigh – Mehran Dadras

15.57 – 16.05h:

Evaluation of outcome measurement tools in patients with Lymphedema – Sally Ng

16.06 – 16.14h:

Treatment of breast cancer-related lymphedema with adipose-derived regenerative cells and fat grafting. An ongoing randomized, placebo-controlled and double-blinded clinical trial – Mads Gustaf Jørgensen

16.15 – 16.23h:

How to predict the sites of target vessels visualized with photoacoustic lymphangiography – Hiroki Kajita

16.24 – 16.32h:

D. Chang / I. Koshima / J. Masià. The use of shave therapy in the surgical treatment of a patient with lymphedema of the lower extremities (clinical case) – Pavel Myshentsev

16.33 – 16.41h:

Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up – Joost Wolfs

16.42 – 16.50h:

Analysis for cases with upper arm edema over 8 years after LVA – Toshiro Mese

16.51 – 16.59h:

Lymphovenous anastomosis for the treatment of thoracic duct lesions and central conducting lymphatic anomalies (CCLA) – Nicole Lindenblatt